Timing Matters: A Meta‐Analysis of BREAST‐Q Administration in Tissue‐Expander and Implant‐Based Breast Reconstruction
Journal of Surgical Oncology · 10.08.2026
DOI: 10.1002/jso.70374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 10.08.2026. Verfasst von Emanuella M Brito und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio, USA. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
BREAST‐Q is the most widely used patient‐reported outcome measure following breast reconstruction, yet no consensus exists on optimal timing or duration of administration. We analyzed BREAST‐Q follow‐up after implant‐based reconstruction, comparing direct‐to‐implant (DTI) and two‐stage tissue expander (TE), to determine how outcomes differ over time and when they stabilize.
Methods
Following PRISMA guidelines, PubMed, Embase, Cochrane, Ovid, and Web of Science were searched for studies administering BREAST‐Q after implant‐based reconstruction. Random‐effects meta‐analysis and meta‐regression compared pooled mean scores across five domains from preoperative baseline through 2 years postoperatively.
Results
Fourteen studies, including 3768 patients, met the inclusion criteria. Among TE patients, psychosocial well‐being was higher at 12–16 months than at baseline ( p = 0.022), whereas physical well‐being was below baseline within the first 6 months ( p = 0.028). Among DTI patients, physical well‐being increased between 3 and 6 and 12–16 months ( p = 0.048), then declined by 18–24 months ( p = 0.031), while sexual well‐being improved by 12–16 months and remained elevated through 18–24 months ( p = 0.026 and p = 0.045). Pooled scores did not differ significantly between TE and DTI in any domain.
Conclusion
BREAST‐Q outcomes remain dynamic during the first 2 postoperative years, supporting follow‐up through at least 18–24 months to better capture long‐term patient‐reported outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Surgery, Dr. Kiran C Patel College of Osteopathic Medicine, NSU, Fort Lauderdale, Florida, USA.
- Department of Surgery, Westside Hospital, Plantation, Florida, USA.
- Department of Plastic Surgery, Cleveland Clinic, Weston, Florida, USA.
- Department of Surgery, Holy Cross Hospital, Fort Lauderdale, Florida, USA.
- Department of Surgery, Baptist Health South Florida, Miami, Florida, USA.
ORCID-Profile: Emanuella M Brito, Natalia Correa
Zitieren
APA
Brito, E. M., Bernal, I., Park, S. K., Armstrong, J. L., Correa, N., Pasarin, A., Tousimis, A., Schwarz, G. S., & Newman, M. I. (2026). Timing Matters: A Meta‐Analysis of BREAST‐Q Administration in Tissue‐Expander and Implant‐Based Breast Reconstruction. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70374
Vancouver
Brito EM, Bernal I, Park SK, Armstrong JL, Correa N, Pasarin A, et al. Timing Matters: A Meta‐Analysis of BREAST‐Q Administration in Tissue‐Expander and Implant‐Based Breast Reconstruction. Journal of Surgical Oncology. 2026. doi:10.1002/jso.70374
BibTeX
@article{Brito2026,
author = {Brito, Emanuella M and Bernal, Isabel and Park, Sean K and Armstrong, Julia L and Correa, Natalia and Pasarin, Anthony and Tousimis, Anastasia and Schwarz, Graham S and Newman, Martin I},
title = {Timing Matters: A Meta‐Analysis of BREAST‐Q Administration in Tissue‐Expander and Implant‐Based Breast Reconstruction},
journal = {Journal of Surgical Oncology},
year = {2026},
doi = {10.1002/jso.70374}
}
EUVIMED